Back
Kezar Life Sciences, Inc. 10K Form
Sell
44
KZR
Kezar Life Sciences, Inc.
Last Price:
$6.23
Seasonality Move:
-4.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KZR News And Ratings
See the #1 stock for the next 7 days that we like better than KZR
KZR Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-9.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.33 |
| Price / Book: | 0.55 |
Profitability
| EPS (TTM): | -8.44330 |
|---|---|
| Net Income (TTM): | $-61.7M |
| Gross Margin: | $-1M |
| Return on Equity: | -58.35% |
| Return on Assets: | -48.14% |
Kezar Life Sciences, Inc. Earnings Forecast
Key Kezar Life Sciences, Inc. Financial Ratios
-
Per Share Earnings over the last 9 years have been positive in 5 years.
Kezar Life Sciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KZR |
| CUSIP: | 49372L |
| Website: | kezarlifesciences.com |
Debt
| Debt-to-Equity Ratio: | 0.12 |
|---|---|
| Current Ratio: | 7.07 |
| Quick Ratio: | 6.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KZR Technical Analysis vs Fundamental Analysis
Sell
44
Kezar Life Sciences, Inc. (KZR)
is a Sell
Is Kezar Life Sciences, Inc. a Buy or a Sell?
-
Kezar Life Sciences, Inc. stock is rated a SellThe current Kezar Life Sciences, Inc. [KZR] share price is $6.25. The Score for KZR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.